drugset / Trial / NCT01479231
Predictors of Proton Pump Inhibitor (PPI) Response in Eosinophilic Esophagitis
NaSingle-groupOpen-labelTreatment
Summary
The investigators will determine the prevalence of gastroesophageal reflux disease (GERD) in Eosinophilic Esophagitis (EoE) and importantly determine the predictors of response to Proton Pump Inhibitor (PPI) therapy in EoE. Moreover, the investigators will determine the effect of GERD on the location of esophageal eosinophilia.
Timeline
- Start
- 2012-03
- Primary completion
- 2012-03
- Completion
- 2012-03
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Dexlansoprazole | Other / unclassified | 60 mg | — |